The abnormal eosinophils are part of the leukemic cell population in acute myelomonocytic leukemia with abnormal eosinophils (AML M4Eo) and carry the pericentric inversion 16: A combination of May-Grünwald-Giemsa staining and fluorescence in situ hybridization

Blood

Volumn 87, Issue 6, 1996, Pages 2459-2463

  Haferlach, Torsten ^a   Winkemann, Martin ^b   Löffler, Helmut ^b   Schoch, Robert ^b   Gassmann, Winfried ^b   Fonatsch, Christa ^b   Schoch, Claudia ^b   Poetsch, Micaela ^b   Weber Matthiesen, Klaus ^b   Schlegelberger, Brigitte ^b  

^a UNIVERSITY OF KIEL   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE MYELOMONOCYTIC LEUKEMIA; ADULT; ARTICLE; CANCER GENETICS; CHROMOSOME 16; CHROMOSOME ANALYSIS; CHROMOSOME INVERSION; CLINICAL ARTICLE; EOSINOPHIL; FLUORESCENCE IN SITU HYBRIDIZATION; GIEMSA STAIN; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; YEAST ARTIFICIAL CHROMOSOME;

ADULT; BONE MARROW; CHROMOSOMES, HUMAN, PAIR 16; CLONE CELLS; COLORING AGENTS; EOSINE YELLOWISH-(YS); EOSINOPHILS; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; INVERSION, CHROMOSOME; LEUKEMIA, MYELOMONOCYTIC, ACUTE; MALE; METHYLENE BLUE; MIDDLE AGED; TUMOR STEM CELLS;

EID: 0030003852     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.6.2459.bloodjournal8762459     Document Type: Article

References (36)

1. Bennett JM, Catovsky D, Daniel MT, Flandrin G, Galton DAG, Gralnick HR, Sultan C: Proposed revised criteria for the classification of acute myeloid leukemia: A report of the French-American-British Cooperative Group. Ann Intern Med 103:626, 1985
2. Arthur DC, Bloomfield CD: Partial deletion of the long arm of chromosome 16 and bone marrow eosinophilia in acute nonlymphocytic leukemia: A new association. Blood 61:994, 1983
3. Le Beau MM, Larson RA, Bitter MA, Vardiman JW, Golomb HM, Rowley JD: Association of an inversion of chromosome 16 with abnormal marrow eosinophils in acute myelomonocytic leukemia: A unique cytogenetic-clinicopathological association. N Engl J Med 309:630, 1983
4. Plantier I, Lai JL, Wattel E, Bauters F, Fenaux P: inv(16) may be one of the only 'favorable' factors in acute myeloid leukemia: A report on 19 cases with prolonged follow-up. Leuk Res 18:885, 1994
5. Haferlach T, Gassmann W, Löffler H, Jürgensen C, Noak J, Ludwig W-D, Thiel E, Haase D, Fonatsch C, Becher R, Schlegelberger B, Nowrousian MR, Lengfelder E, Eimermacher H, Weh HJ, Braumann D, Maschmeyer G, Koch P, Heinecke A, Sauerland MC, Büchner T: Clinical aspects of acute myeloid leukemias of the FAB types M3 and M4Eo. Ann Hematol 66:165, 1993
6. Haferlach T, Löffler H, Bennett JM, Andersen JW, Gassmann W, Ludwig W-D, Thiel E, Paietta E, Cassileth PA, Fonatsch C, Schoch C, Schlegelberger B, Becher R, Sauerland MC, Heinecke A, Büchner T for the AML Cooperative Group and ECOG: Cytomorphology and clinical outcome in 54 patients with AML M4Eo and inversion 16. Ann Hematol 70:126, 1995 (abstr)
7. Löffler H: Zytochemische Klassifizierung der akuten Leukosen, in Stacher A (ed): Chemotherapie und Immuntherapie der Leukosen und malignen Lymphome. Bohmann-Verlag, Wien, 1969, p 120
8. Löffler H: Indications and limits of cytochemistry in acute leukemia. Rec Res Canc Res 43:57, 1973
9. Leder LD: Akute myelomonozytäre Leukämie mit atypischen Naphtol-AS-D-Chloroacetat-Esterase-positiven Eosinophilen. Acta Haematol 44:52, 1970
10. Bitter MA, Le Beau MM, Larson RA, Rosner MC, Harvey BA, Golomb HM, Rowley JD, Vardiman JW: A morphologic and cytochemical study of acute myelomonocytic leukemia with abnormal marrow eosinophils associated with in(16)(p13q22). Am J Clin Pathol 81:733, 1984
11. Bitter MA, Le Beau MM, Rowley JD, Larson RA, Golomb HM, Vardiman JW: Associations between morphology, karyotype, and clinical features in myeloid leukemias. Hum Pathol 18:211, 1987
12. Berger R, Bernheim A, Daniel MT, Valensi F, Sigaux F, Flandrin G: Cytogenetic studies on acute myelomonocytic leukaemia (M4) with eosinophilia. Leuk Res 9:279, 1985
13. Bloomfield C, Arthur DC: Del(16)(q21 or 22) and marrow eosinophilia in acute nonlymphocytic leukemia (ANLL): A new cytogenetic-clinical association. Proc Am Soc Clin Oncol 38:191, 1982 (abstr)
14. Liu P, Claxton DF, Marlton P, Hajra A, Siciliano J, Freedman M, Chandrasekharappa SC, Yanagisawa K, Stallings RL, Collins FS, Siciliano MJ: Identification of yeast artificial chromosomes containing the inversion 16 p-arm breakpoint associated with acute myelomonocytic leukemia. Blood 82:716, 1993
15. Liu P, Tarle SA, Hajra A, Claxton DF, Marlton P, Freedman M, Siciliano MJ, Collins FS: Fusion between transcription factor CBF β /PEB β and a myosin heavy chain in acute myeloid leukemia. Science 261:1041, 1993
16. Claxton DF, Liu P, Hsu HB, Marlton P, Hester J, Collins F, Deisseroth AB, Rowley JD, Siciliano MJ: Detection of fusion transcripts generated by the inversion 16 chromosome in acute myelogenous leukemia. Blood 83:1750, 1994
17. Marlton P, Claxton DF, Liu P, Estey EH, Beran M, LeBeau M, Testa JR, Collins FS, Rowley JD, Siciliano MJ: Molecular characterization of 16p deletions associated with inversion 16 defines the critical fusion for leukemogenesis. Blood 85:772, 1995
18. Poirel H, Radford-Weiss I, Rack K, Troussard X, Veil A, Valensi F, Picard F, Guesnu M, Leboeuf D, Melle J, Dreyfus F, Flandrin G, Macintyre E: Detection of the chromosome 16 CBF β -MYH11 fusion transcript in myelomonocytic leukemias. Blood 85:1313, 1995
19. Liu PP, Wijmenga C, Collins FS: Molecular pathogenesis of chromosome 16 inversion in the M4Eo subtype of acute myeloid leukemia. Blood 85:2289, 1995
20. Mitelman F (ed): ISCN 1991, Guidelines for Cancer Cytogenetics: Supplement to An International System for Human Cytogenetic Nomenclature. Basel, Switzerland, Karger Verlag, 1991 p 1
21. Schoch R, Jenisch S, Haferlach T, Müller-Ruchholtz W, Gassmann W, Löffler H: Glass slide smears are a suitable source for RT-PCR-based analysis of chromosomal aberrations in leukaemias. Br J Haematol (in press)
22. Anastasi J, Vardiman JW, Rudinsky R, Patel M, Nachman J, Rubin CM, Le Beau MM: Direct correlation of cytogenetic findings with cell morphology using in situ hybridization: An analysis of suspicious cells in bone marrow specimen of two patients completing therapy for acute lymphoblastic leukemia. Blood 77:2456, 1991
23. Weber-Matthiesen K, Winkemann M, Müller-Hermelink A, Schlegelberger B, Grote W: Simultaneous fluorescence immunophenotyping and interphase cytogenetics: A contribution to the characterization of tumor cells. J Histochem Cytochem 40:171, 1992
24. Weber-Matthiesen K, Deerberg J, Müller-Hermelink A, Schlegelberger B, Grote W: Rapid immunophenotypic characterization of chromosomally aberrant cells by the new FICTION method. Cytogenet Cell Genet 63:122, 1993
25. Schmitz N, Gödde-Salz E, Gassmann W, Löffler H: Acute myelomonocytic leukemia with involvement of eosinophils and inversion of chromosome 16. Blut 48:263, 1984
26. Larson RA, Williams SF, Le Beau MM, Bitter MA, Vardiman JW, Rowley JD: Acute myelomonocytic leukemia with abnormal eosinophils and inv(16) or t(16; 16) has a favorable prognosis. Blood 68:1242, 1986
27. Nakamura H, Sadamori N, Tagawa M, Sasagawa I, Itoyama T, Yao E-I, Ichimaru M: Inversion of chromosome 16 in bone marrow eosinophils of acute myelomonocytic leukemia (M4) with eosinophilia. Cancer Genet Cytogenet 29:327, 1987
28. Yanagisawa K, Fukuoka T, Fujita S: Evidence for the neoplastic involvement of monocytic, eosinophilic and basophilic lineages in acute myelomonocytic leukemia with eosinophilia. Acta Haematol 83:145, 1990
29. Yanagisawa K, Horiuchi T, Fujita S: Establishment and characterization of a new human leukemia cell line derived from M4Eo. Blood 78:451, 1991
30. Anastasi J, Feng J, Le Beau MM, Larson RA, Rowley JD, Vardiman JW: Cytogenetic clonality in myelodysplastic syndromes studied with fluorescence in situ hybridization: Lineage, response to growth factor therapy, and clone expansion. Blood 81:1580, 1993
31. Anastasi J, Thangavelu M, Vardiman JW, Hooberman AL, Lu Bian M, Larson RA, Le Beau MM: Interphase cytogenetic analysis detects minimal residual disease in a case of acute lymphoblastic leukemia and resolves the question of origin of relapse after allogeneic bone marrow transplantation. Blood 77:1087, 1991
32. Loom van K, Smit EME, Löwenberg B: In situ hybridization on May-Grünwald Giemsa stained bone marrow and blood smears of patients with hematologic disorders allows detection of cell-lineage specific cytogenetic abnormalities. Blood 82:884, 1993
33. Kwong YL, Chan LC: Involvement of eosinophils in acute myeloid leukaemia with monosomy 7 demonstrated by fluorescence in situ hybridization. Br J Haematol 88:389, 1994
34. Kwong YL, Wong ICF, Chan LC: Trisomy 8 in acute promyelocytic leukaemia: An interphase study by fluorescence in situ hybridization Br J Haematol 90:697, 1995
35. Nylund SJ, Ruutu T, Saarinen U, Larramendy ML, Knuutila S: Detection of minimal residual disease using fluorescence DNA in situ hybridization: A follow-up study in leukemia and lymphoma patients. Leukemia 8:587, 1994
36. Zhao L, Chang K-S, Estey EH, Hayes K, Deisseroth AB, Liang JC: Detection of residual leukemic cells in patients with acute promyelocytic leukemia by the fluorescence in situ hybridization method: Potential for predicting relapse. Blood 85:495, 1995